RZLT Cash-Secured Put Strategy

RZLT (Rezolute, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

RZLT (Rezolute, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $318.7M, a beta of 0.67 versus the broader market, a 52-week range of 1.07-11.457, average daily share volume of 2.2M, a public-listing history dating back to 2013, approximately 64 full-time employees. These structural characteristics shape how RZLT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.67 indicates RZLT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a cash-secured put on RZLT?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current RZLT snapshot

As of May 15, 2026, spot at $3.33, ATM IV 108.50%, IV rank 27.08%, expected move 31.11%. The cash-secured put on RZLT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this cash-secured put structure on RZLT specifically: RZLT IV at 108.50% is on the cheap side of its 1-year range, which means a premium-selling RZLT cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 31.11% (roughly $1.04 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RZLT expiries trade a higher absolute premium for lower per-day decay. Position sizing on RZLT should anchor to the underlying notional of $3.33 per share and to the trader's directional view on RZLT stock.

RZLT cash-secured put setup

The RZLT cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RZLT near $3.33, the first option leg uses a $3.16 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RZLT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RZLT shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$3.16N/A

RZLT cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

RZLT cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on RZLT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on RZLT

Cash-secured puts on RZLT earn premium while a trader waits to acquire RZLT stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RZLT.

RZLT thesis for this cash-secured put

The market-implied 1-standard-deviation range for RZLT extends from approximately $2.29 on the downside to $4.37 on the upside. A RZLT cash-secured put lets a trader earn premium while waiting to acquire RZLT at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current RZLT IV rank near 27.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RZLT at 108.50%. As a Healthcare name, RZLT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RZLT-specific events.

RZLT cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RZLT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RZLT alongside the broader basket even when RZLT-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on RZLT carry tail risk when realized volatility exceeds the implied move; review historical RZLT earnings reactions and macro stress periods before sizing. Always rebuild the position from current RZLT chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on RZLT?
A cash-secured put on RZLT is the cash-secured put strategy applied to RZLT (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With RZLT stock trading near $3.33, the strikes shown on this page are snapped to the nearest listed RZLT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are RZLT cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the RZLT cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 108.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a RZLT cash-secured put?
The breakeven for the RZLT cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RZLT market-implied 1-standard-deviation expected move is approximately 31.11%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on RZLT?
Cash-secured puts on RZLT earn premium while a trader waits to acquire RZLT stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RZLT.
How does current RZLT implied volatility affect this cash-secured put?
RZLT ATM IV is at 108.50% with IV rank near 27.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related RZLT analysis